Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002880 |
---|---|
Receipt number | R000003516 |
Scientific Title | Prospective Phase ll trial of Erlotinib for Advanced Non Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations |
Date of disclosure of the study information | 2009/12/11 |
Last modified on | 2023/12/22 12:56:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/12/11 17:51:49 | ||
2 | Update | 2014/06/12 21:55:15 | Last name of lead principal investigator Last name of contact person Last name of contact person Address Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2014/06/12 21:59:38 | Division name Division name |
|
4 | Update | 2023/12/22 12:50:56 | Recruitment status Date of IRB Last follow-up date |
|
5 | Update | 2023/12/22 12:56:58 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Organization Organization Address Address Tel |